Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir (Q38174251)

From Wikidata
Jump to navigation Jump to search
scientific article published on February 2014
edit
Language Label Description Also known as
English
Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir
scientific article published on February 2014

    Statements

    Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir (English)
    1 February 2014
    34 Suppl 1

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit